BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12127536)

  • 1. Discovery of potent, selective human granzyme B inhibitors that inhibit CTL mediated apoptosis.
    Willoughby CA; Bull HG; Garcia-Calvo M; Jiang J; Chapman KT; Thornberry NA
    Bioorg Med Chem Lett; 2002 Aug; 12(16):2197-200. PubMed ID: 12127536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
    Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
    Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
    J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization, application and potential uses of biotin-tagged inhibitors for lymphocyte serine proteases (granzymes).
    Winkler U; Allison NJ; Woodard SL; Gault RA; Ewoldt GR; Kam CM; Abuelyaman A; Powers JC; Hudig D
    Mol Immunol; 1996; 33(7-8):615-23. PubMed ID: 8760273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death.
    Andrade F; Bull HG; Thornberry NA; Ketner GW; Casciola-Rosen LA; Rosen A
    Immunity; 2001 Jun; 14(6):751-61. PubMed ID: 11420045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enzymatic activity of human cytotoxic T-lymphocyte granzyme A and cytolysis mediated by cytotoxic T-lymphocytes are potently inhibited by a synthetic antiprotease, FUT-175.
    Poe M; Wu JK; Blake JT; Zweerink HJ; Sigal NH
    Arch Biochem Biophys; 1991 Jan; 284(1):215-8. PubMed ID: 1989498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; PiƱeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency.
    Hirst CE; Buzza MS; Bird CH; Warren HS; Cameron PU; Zhang M; Ashton-Rickardt PG; Bird PI
    J Immunol; 2003 Jan; 170(2):805-15. PubMed ID: 12517944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating antigen-specific cytotoxicity of CD8+ T cells in fish by granzyme B-like activity.
    Toda H; Yabu T; Shiba H; Moritomo T; Nakanishi T
    Vet Immunol Immunopathol; 2011 May; 141(1-2):168-72. PubMed ID: 21435730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTL lysis: there is a hyperbolic relation of killing rate to exocytosable granzyme A for highly cytotoxic murine cytotoxic T lymphocytes.
    Poe M; Wu JK; Talento A; Koo GC
    J Immunol Methods; 1996 Jun; 192(1-2):37-41. PubMed ID: 8699020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.
    Motyka B; Korbutt G; Pinkoski MJ; Heibein JA; Caputo A; Hobman M; Barry M; Shostak I; Sawchuk T; Holmes CF; Gauldie J; Bleackley RC
    Cell; 2000 Oct; 103(3):491-500. PubMed ID: 11081635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors.
    Kam CM; Hudig D; Powers JC
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):307-23. PubMed ID: 10708866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for heat shock protein 27 in CTL-mediated cell death.
    Beresford PJ; Jaju M; Friedman RS; Yoon MJ; Lieberman J
    J Immunol; 1998 Jul; 161(1):161-7. PubMed ID: 9647220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective chemical functional probes of granzymes A and B reveal granzyme B is a major effector of natural killer cell-mediated lysis of target cells.
    Mahrus S; Craik CS
    Chem Biol; 2005 May; 12(5):567-77. PubMed ID: 15911377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granzyme B.
    Peitsch MC; Tschopp J
    Methods Enzymol; 1994; 244():80-7. PubMed ID: 7845246
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of serine protease with the rise of intracellular calcium in cytotoxic T lymphocytes.
    Koo GC; Luk Y; Talento A; Wu J; Sirotina A; Fischer PA; Blake JT; Nguyen MP; Parsons W; Poe M
    Cell Immunol; 1996 Dec; 174(2):107-15. PubMed ID: 8954610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
    Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
    Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B.
    Mahrus S; Kisiel W; Craik CS
    J Biol Chem; 2004 Dec; 279(52):54275-82. PubMed ID: 15494398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.